Synopsis
0
USDMF
0
JDMF
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
API SUPPLIERS
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Shanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API Imports and Exports
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Related Excipient Companies
Minakem
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SPI Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharm-RX Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Faran Shimi Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Healthcare
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Nanjing Well Pharmaceutical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pfanstiehl
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Actylis
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DFE Pharma
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Finar
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Gangwal Chemicals
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ideal Cures Pvt Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Ingredion Pharma Solutions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Kerry
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Microlex e.U
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pharmatrans-Sanaq
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Pluviaendo
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Prachin Chemical
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Roquette
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Seppic
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Shanghai Shenmei Pharmaceutical Technology Co., Ltd
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Sigachi Industries
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Fillers, Diluents & Binders
Direct Compression
Disintegrants & Superdisintegrants
Thickeners and Stabilizers
Co-Processed Excipients
Lubricants & Glidants
Granulation
Parenteral
Taste Masking
Coating Systems & Additives
Controlled & Modified Release
Chewable & Orodispersible Aids
Film Formers & Plasticizers
Topical
Emulsifying Agents
API Stability Enhancers
Solubilizers
Rheology Modifiers
Digital Content
NEWS #PharmaBuzz
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Milbemycin Oxime manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Milbemycin Oxime, including repackagers and relabelers. The FDA regulates Milbemycin Oxime manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Milbemycin Oxime API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Milbemycin Oxime manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Milbemycin Oxime supplier is an individual or a company that provides Milbemycin Oxime active pharmaceutical ingredient (API) or Milbemycin Oxime finished formulations upon request. The Milbemycin Oxime suppliers may include Milbemycin Oxime API manufacturers, exporters, distributors and traders.
click here to find a list of Milbemycin Oxime suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Milbemycin Oxime CEP of the European Pharmacopoeia monograph is often referred to as a Milbemycin Oxime Certificate of Suitability (COS). The purpose of a Milbemycin Oxime CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Milbemycin Oxime EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Milbemycin Oxime to their clients by showing that a Milbemycin Oxime CEP has been issued for it. The manufacturer submits a Milbemycin Oxime CEP (COS) as part of the market authorization procedure, and it takes on the role of a Milbemycin Oxime CEP holder for the record. Additionally, the data presented in the Milbemycin Oxime CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Milbemycin Oxime DMF.
A Milbemycin Oxime CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Milbemycin Oxime CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Milbemycin Oxime suppliers with CEP (COS) on PharmaCompass.
A Milbemycin Oxime written confirmation (Milbemycin Oxime WC) is an official document issued by a regulatory agency to a Milbemycin Oxime manufacturer, verifying that the manufacturing facility of a Milbemycin Oxime active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Milbemycin Oxime APIs or Milbemycin Oxime finished pharmaceutical products to another nation, regulatory agencies frequently require a Milbemycin Oxime WC (written confirmation) as part of the regulatory process.
click here to find a list of Milbemycin Oxime suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Milbemycin Oxime as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Milbemycin Oxime API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Milbemycin Oxime as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Milbemycin Oxime and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Milbemycin Oxime NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Milbemycin Oxime suppliers with NDC on PharmaCompass.
Milbemycin Oxime Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Milbemycin Oxime GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Milbemycin Oxime GMP manufacturer or Milbemycin Oxime GMP API supplier for your needs.
A Milbemycin Oxime CoA (Certificate of Analysis) is a formal document that attests to Milbemycin Oxime's compliance with Milbemycin Oxime specifications and serves as a tool for batch-level quality control.
Milbemycin Oxime CoA mostly includes findings from lab analyses of a specific batch. For each Milbemycin Oxime CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Milbemycin Oxime may be tested according to a variety of international standards, such as European Pharmacopoeia (Milbemycin Oxime EP), Milbemycin Oxime JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Milbemycin Oxime USP).
LOOKING FOR A SUPPLIER?
